TELA Bio, Inc.
TELA
$2.03
$0.084.10%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -22.33% | 11.22% | 17.68% | -122.58% | 56.08% |
Total Depreciation and Amortization | 0.38% | 1.14% | 5.62% | 6.41% | 45.34% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -24.91% | 32.31% | 19.12% | 127.02% | -423.95% |
Change in Net Operating Assets | 45.07% | -43.01% | -918.89% | 102.84% | -2,806.42% |
Cash from Operations | -29.13% | 16.16% | 16.02% | 25.63% | -30.16% |
Capital Expenditure | 87.88% | -116.39% | 59.20% | 1.64% | -48.29% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 103.17% | -- | -100.00% | -92.68% | -- |
Cash from Investing | 172.63% | -55.74% | -282.09% | -98.57% | 2,533.16% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -99.86% | 36,582.91% | 1,850.00% | -98.44% | 1,376.92% |
Repurchase of Common Stock | -1,509.09% | 42.11% | -72.73% | 96.65% | -8,100.00% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -100.27% | 43,683.67% | 2,060.00% | -108.93% | 154.55% |
Foreign Exchange rate Adjustments | -173.63% | 196.81% | -1,466.67% | -126.09% | 228.57% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -127.81% | 484.65% | 13.64% | -11.07% | 14.47% |